PFBT
AVXL icon

Parkside Financial Bank & Trust’s Anavex Life Sciences AVXL Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$400 Buy
+130
New +$563 ﹤0.01% 2590
2025
Q4 		– Sell
-60
Closed -$534 – 2697
2025
Q3 		$534 Hold
60
– – ﹤0.01% 2551
2025
Q2 		$554 Hold
60
– – ﹤0.01% 2487
2025
Q1 		$515 Buy
+60
New +$567 ﹤0.01% 2364

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Parkside Financial Bank & Trust's AVXL Position: Q1 2026 in Review

Parkside Financial Bank & Trust opened a new position in Anavex Life Sciences (AVXL) in Q1 2026: 130 shares worth $400. The stake represents ﹤0.01% of the portfolio and ranks #2590 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in AVXL as recently as Q3 2025.

Parkside Financial Bank & Trust first reported a position in AVXL in Q1 2025 and has held it in 4 quarters since. The position peaked at $554 in Q2 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Parkside Financial Bank & Trust held 130 shares of Anavex Life Sciences worth $400 as of Q1 2026.
  • Anavex Life Sciences was a new Parkside Financial Bank & Trust position in Q1 2026.
  • Anavex Life Sciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2590 holding.
  • Parkside Financial Bank & Trust first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Anavex Life Sciences position peaked at $554 in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.